After several years of restructuring, Switzerland-based Clariant is looking to develop its second-generation bioethanol technology – which uses crops to create biofuel – as a direct result of its $2.5 billion buyout of Sued-Chemie. The company, purchased in 2011, focuses on catalyst making and has reportedly allowed for Clariant to utilize more advanced technology and research. The company has now announced new testing of that technology in efforts to strengthen its stance against rivals Royal DSM NV and Novosymes A/S. Testing is reportedly going on in Munich, Germany. The company is also planning to sell three of its commodity-chemical units for $1.3 billion to re-invest profits into the project. Clariant says the deals will be finalized by the end of this September.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Turkey Hits Meta with $37.20 Million Fine Over Data-Sharing Practices
May 8, 2024 by
CPI
Google Seeks Dismissal of UK Suit Over Alleged Anti-Competitive Practices
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI